You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 452 Combination treatment using KISIMATM protein-based cancer vaccine and systemic STING agonist results in profound modulation of tumor microenvironment and improved tumor control

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Combination immunotherapies
452 Combination treatment using KISIMATM protein-based cancer vaccine and systemic STING agonist results in profound modulation of tumor microenvironment and improved tumor control

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020129014
Dec 20202807
Jan 20212005
Feb 20212604
Mar 20213804
Apr 20212203
May 2021301
Jun 20210010
Jul 2021004
Aug 2021005
Sep 2021005
Oct 202118012
Nov 202122018
Dec 2021602
Jan 20221204
Feb 20221402
Mar 20221601
Apr 20222802
May 20221600
Jun 20222000
Jul 20221602
Aug 20222203
Sep 20221000
Oct 20222601
Nov 20221200
Dec 20221402
Jan 20232801
Feb 20231001
Mar 20231201
Apr 20232204
May 20231202
Jun 2023601
Jul 2023602
Aug 20231201
Sep 2023401
Oct 20231201
Nov 20232202
Dec 20232800
Jan 20241800
Feb 20241400
Mar 20242001
Apr 20241602
May 20241600
Jun 20242600
Jul 20242801
Aug 20241002
Sep 20242603
Oct 20243004
Nov 20245407
Dec 2024805
Jan 20253407
Feb 2025802
Mar 20250010
Apr 2025003
May 2025004
Jun 2025004
Total10000183